ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

アジナゾラム

Adinazolam

HCID 37632
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
37115-32-5
標準SMILES
CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
InChIKey
GJSLOMWRLALDCT-UHFFFAOYSA-N
分子式
C19H18ClN5
平均分子量
351.8 g/mol
単同位体質量
351.1250733

概要

Adinazolam is a triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position. It has a role as an antidepressant, an anxiolytic drug, an anticonvulsant and a sedative.

名称と識別子

優先名称
Adinazolam
IUPAC
1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine
現地名
アジナゾラム
英語名
ADINAZOLAM
分子式
C19H18ClN5
分子量
351.83

名称と別名

ADINAZOLAM37115-32-5AdinazolamumU-411238-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepineDTXSID40190611U-41,123KN08449444CHEBI:2514128-chloro-1-[(dimethylamino)methyl]-6-phenyl-4h-s-triazolo[4,3-a][1,4]benzodiazepine((12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),3,5,8,11,13-hexaen-3-yl)methyl)dimethylamine({12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methyl)dimethylamine
名称をさらに表示
アジナゾラム8-クロロ-N,N-ジメチル-6-フェニル-4H-[1,2,4]トリアゾロ[4,3-a][1,4]ベンゾジアゼピン-1-メタンアミン({12-クロロ-9-フェニル-2,4,5,8-テトラアザトリシクロ[8.4.0.02,6]テトラデカ-1(14),3,5,8,10,12-ヘキサエン-3-イル}メチル)ジメチルアミンAdinazolam (CRM)Adinazolam solution8-Chloro-N,N-dimethyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-1-methanamine4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-1-methanamine, 8-chloro-N,N-dimethyl-6-phenyl-γ-Aminobutyric acid Receptor,sickness,antihistamine,GABA Receptor,inhibit,Adinazolam,U-41123,U 41123,Huntington,Gamma-aminobutyric acid Receptor,anti-motion,piperazine,U41123,Inhibitor

物性

構造計算による物性補完中

XLogP
1.6
極性表面積
46.3 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
3
重原子数
25
形式電荷
0
複雑度
490

実験および物理化学的性質

Drugs · 3 件

DEA NFLIS-Drug Category -> Benzodiazepines

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP4.4
Solubility6.72e-02 g/L
Physical DescriptionSolid

物理化学的性質

融点
171 · 171-172.5° (US 4250094); mp 165-166° (DE 2201210)
沸点
527 · 527.0±60.0 °C(Predicted)
比重(密度)
1.31 · 1.31±0.1 g/cm3(Predicted)
貯蔵温度
-10 to · -10 to -25°C
外見
Solid
酸解離定数(Pka)
6.2 · pKa 6.2 (D2O/DClor D2O/NaOD ) (Uncertain);5.8±0.1(D2O/DClor D2O/NaOD ) (Uncertain)
色
White to off-white
InChI
1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3
InChIKey
GJSLOMWRLALDCT-UHFFFAOYSA-N

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全データ

wgk
WGK 2
ridadr
3249
hazard_class
6.1(b)
packing_group
III
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralEye Irrit. 2Flam. Liq. 2
ストレージクラス
3 - Flammable liquids

化学と産業

薬理情報

ATC Code · 2 件

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1 件

Adinazolam is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Adinazolam binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.

Mechanism of Action · 1 件

Adinazolam binds to peripheral-type benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.

Biological Half-LifeLess than 3 hours.
Metabolism/Metabolites · 2 件

The drug primarily undergoes hepatic metabolism to form the main metabolite N-desmethyladinazolam, alpha-hydroxyalprazolam, and estazolam.

Adinazolam has known human metabolites that include N-demethyladinazolam.

MeSH Pharmacological Classification · 1 件

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.

Cellular LocationsMembrane

関連反応

5 件
反応記録を作成
HRID 268532 の反応式
HRID 268532生成物として
HRID 441386 の反応式
HRID 441386生成物として
HRID 903029 の反応式
HRID 903029生成物として
HRID 1679592 の反応式
HRID 1679592生成物として
HRID 2161108 の反応式
HRID 2161108生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
RefChem:553043DTXCID80113102N05BA07Adinazolamum [INN-Latin]Deracyn1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamineU 41123Adinazolam [USAN]

データベース識別子

CAS
37115-32-5
PubChem CID
37632
DTXSID
DTXSID40190611
ChEMBL
CHEMBL328250
ChEBI
CHEBI:251412
UNII
KN08449444
Nikkaji
J19.718A
SMILES
Clc1cc2c(cc1)[n]3c(nnc3CN(C)C)CN=C2c4ccccc4

応用分野

使用Antidepressant; sedative-hypnotic.

補足説明

定義ChEBI: A triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position.